孕19-23周母体心脏功能对妊娠期糖尿病的预测价值
前瞻性观察研究纳入2853例孕妇,199例(7.0%)发生妊娠期糖尿病。孕19-23周超声心动图显示,妊娠期糖尿病组在外周血管阻力和心肌做功指数上轻度升高,但校正母体特征和病史后,加入心血管指标并未改善对妊娠期糖尿病的筛查效能。
要点
- 孕19-23周妊娠期糖尿病组外周血管阻力和心肌做功指数较非糖尿病组轻度升高,但差异微小。
- 校正母体特征和病史后,仅外周血管阻力和心肌做功指数在两组间有显著差异。
- 在母体因素基础上加入心血管指标未提高妊娠期糖尿病筛查的检出率。
核心结论
- 妊娠期糖尿病孕妇在发病前已存在轻微的功能和血流动力学心脏改变。
- 这些心脏改变大多与这些孕妇的不良危险因素特征相关。
- 孕20周母体心脏评估对妊娠期糖尿病发生的预测并不比基于母体特征和病史计算的风险提供更多信息。
研究设计与样本
- 前瞻性观察性研究,纳入孕19+1至23+3周常规就诊孕妇2853例,其中199例(7.0%)发生妊娠期糖尿病。
- 采用母体超声心动图评估E/A比值、E/e'比值、心肌做功指数、整体纵向收缩应变、左心室射血分数、外周血管阻力、左心室心输出量和经体表面积标化的左心室质量。
- 心脏指标经标准化处理以去除母体特征和病史因素的影响,比较妊娠期糖尿病组与非糖尿病组的校正值。
诊断标准与关键数值
- 妊娠期糖尿病组与非糖尿病组在E/A比值、E/e'比值、心肌做功指数和整体纵向收缩应变上存在显著差异。
- 校正母体特征和病史后,仅外周血管阻力和心肌做功指数在两组间有显著差异,且均在妊娠期糖尿病组轻度升高。
- 基于母体特征和病史联合心血管指标筛查妊娠期糖尿病的受试者工作特征曲线下面积及在10%、20%、40%假阳性率下的检出率已确定,但原文未报告具体数值。
临床应用与阅片要点
- 孕20周母体心脏评估不作为妊娠期糖尿病的额外预测工具,筛查仍应基于母体特征和病史。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To examine differences in maternal cardiovascular indices at 19-23 weeks' gestation between pregnancies that develop gestational diabetes mellitus (GDM) and those without GDM, and to determine whether such cardiovascular changes are the consequence of maternal demographic characteristics and medical history or GDM per se.
METHODS: This was a prospective observational study in women attending for a routine hospital visit at 19 + 1 to 23 + 3 weeks' gestation. This visit included recording of maternal demographic characteristics and medical history, and maternal echocardiography for assessment of E/A ratio, E/e' ratio, myocardial performance index, global longitudinal systolic strain, left ventricular ejection fraction, peripheral vascular resistance, left ventricular cardiac output and left ventricular mass indexed for body surface area. The measurements of the maternal cardiac indices were standardized to remove the effects of maternal characteristics and elements from the medical history, and the adjusted values in the GDM group were compared to those in the non-GDM group. Likelihood ratios were derived for those indices that were altered significantly in GDM, and these were used to modify the prior risk derived from maternal demographic characteristics and medical history. The area under the receiver-operating-characteristics curve and the detection rate of GDM, at 10%, 20% and 40% false-positive rates, in screening by a combination of maternal factors with cardiovascular indices were determined.
RESULTS: The study population of 2853 pregnancies contained 199 (7.0%) that developed GDM. In pregnancies that developed GDM, there were significant differences from the non-GDM group in E/A ratio, E/e' ratio, myocardial performance index and global longitudinal systolic strain. After adjustment for maternal demographic characteristics and factors from the medical history known to affect cardiac indices, the only cardiovascular indices that were significantly different between the GDM and non-GDM groups were peripheral vascular resistance and myocardial performance index, both of which were marginally increased in the GDM group. The performance of screening for GDM by maternal demographic characteristics and medical history was not improved by the addition of cardiovascular indices.
CONCLUSIONS: Women with GDM have subtle functional and hemodynamic cardiac changes prior to the development of GDM. These cardiac changes are mostly related to the adverse risk-factor profile of these women. Maternal cardiac assessment at 20 weeks does not offer additional predictive information for GDM development in pregnancy to that calculated based on demographic characteristics and medical history. © 2021 International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Gibbone E, Wright A, Campos RV, et al. Maternal cardiac function at 19-23 weeks' gestation in prediction of gestational diabetes mellitus. Ultrasound Obstet Gynecol. 2021. PMID: 33428303. doi:10.1002/uog.23589
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。